• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,867.48 179.64
(0.35%)
Dow Jones
7,378.60 -7.86
(-0.11%)
Hang Seng
72,467.78 3,292.81
(4.76%)
Nikkei 225
10,453.87 25.02
(0.24%)
Forex
USD-INR
94.74 0.21
(0.22%)
EUR-INR
108.00 -0.19
(-0.17%)
GBP-INR
125.20 0.11
(0.09%)
JPY-INR
0.59 0.00
(0.26%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2358719
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
55.76
10238.55
EPS(TTM)
Face Value()
Div & Yield %
19.92
10
0.45
 

Prime Fresh consolidated net profit rises 47.67% in the March 2026 quarter
May 21,2026
Net profit of Prime Fresh rose 47.67% to Rs 2.85 crore in the quarter ended March 2026 as against Rs 1.93 crore during the previous quarter ended March 2025. Sales rose 49.98% to Rs 79.91 crore in the quarter ended March 2026 as against Rs 53.28 crore during the previous quarter ended March 2025.

For the full year,net profit rose 44.85% to Rs 13.21 crore in the year ended March 2026 as against Rs 9.12 crore during the previous year ended March 2025. Sales rose 32.50% to Rs 273.98 crore in the year ended March 2026 as against Rs 206.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales79.9153.28 50 273.98206.77 33
OPM %6.425.80 -7.045.99 -
PBDT5.113.14 63 19.3012.93 49
PBT5.023.09 62 18.9712.73 49
NP2.851.93 48 13.219.12 45